Skip to main content

Ani Pharmaceuticals Inc

ANIP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001023024

In the last 90 days, Ani Pharmaceuticals Inc insiders filed 0 open-market purchases and 10 sales; 307 institutions reported holding it in 13F filings for Q2 2026, worth $1.90B in total; no superinvestor holds it.

13F holders, Q1 2021

Institutional positions in Ani Pharmaceuticals Inc as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
106
No complete 13F data for Q4 2020
Shares held
7.29M
No complete 13F data for Q4 2020
Total value
$263.5M
No complete 13F data for Q4 2020

Holders and value by quarter

Institutions reporting ANIP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2021: 106 institutions
Q1 2021: 106 institutionsQ2 2021: 116 institutionsQ3 2021: 118 institutionsQ4 2021: 132 institutionsQ1 2022: 126 institutionsQ2 2022: 120 institutionsQ3 2022: 126 institutionsQ4 2022: 126 institutionsQ1 2023: 138 institutionsQ2 2023: 172 institutionsQ3 2023: 186 institutionsQ4 2023: 181 institutionsQ1 2024: 200 institutionsQ2 2024: 201 institutionsQ3 2024: 208 institutionsQ4 2024: 206 institutionsQ1 2025: 231 institutionsQ2 2025: 233 institutionsQ3 2025: 269 institutionsQ4 2025: 285 institutionsQ1 2026: 281 institutionsQ2 2026: 307 institutions
Value heldQ1 2021: $263.5M
Q1 2021: $263.5MQ2 2021: $252.7MQ3 2021: $238.8MQ4 2021: $413.4MQ1 2022: $258.8MQ2 2022: $293.4MQ3 2022: $330.3MQ4 2022: $412.4MQ1 2023: $411.7MQ2 2023: $662.5MQ3 2023: $766.4MQ4 2023: $750.8MQ1 2024: $975.2MQ2 2024: $962.3MQ3 2024: $1.12BQ4 2024: $1.07BQ1 2025: $1.34BQ2 2025: $1.29BQ3 2025: $1.87BQ4 2025: $1.67BQ1 2026: $1.80BQ2 2026: $1.90B
Institutions holding ANIP and their total value by quarter
QuarterHoldersValue
Q2 2026307$1.90B
Q1 2026281$1.80B
Q4 2025285$1.67B
Q3 2025269$1.87B
Q2 2025233$1.29B
Q1 2025231$1.34B
Q4 2024206$1.07B
Q3 2024208$1.12B
Q2 2024201$962.3M
Q1 2024200$975.2M
Q4 2023181$750.8M
Q3 2023186$766.4M
Q2 2023172$662.5M
Q1 2023138$411.7M
Q4 2022126$412.4M
Q3 2022126$330.3M
Q2 2022120$293.4M
Q1 2022126$258.8M
Q4 2021132$413.4M
Q3 2021118$238.8M
Q2 2021116$252.7M
Q1 2021106$263.5M

Institutions, Q1 2021

Shares, value and share of portfolio for each institution holding Ani Pharmaceuticals Inc.

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.

Institutions holding ANIP in Q1 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Goldman Sachs Group Inc338,368$12.2M0.00%––
Investment Counselors of Maryland LLC352,014$12.7M0.33%––
State Street Corp394,992$14.3M0.00%––
Dimensional Fund Advisors LP408,314$14.7M0.00%––
Vanguard Group Inc659,005$23.8M0.00%––
BlackRock Inc.1,651,285$59.7M0.00%––